Amgen (AMGN) will invest an initial $200 million this year in its new technology center in southern India, Reuters reported Monday, citing Chief Executive Robert Bradway.
The US drugmaker has also planned "significant" investments for future years as part of its plan to expand its presence in India, according to the report.
By the end of the year, the site in Hyderabad city is expected to have a workforce of roughly 2,000, Reuters reported, citing Som Chattopadhyay, national executive for India at Amgen.
Amgen did not immediately respond to MT Newswires' request for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。